HEADER TRANSFERASE/ANTIBIOTIC 29-AUG-18 6MB5 TITLE AAC-IIIB BINARY WITH NEOMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: AAC(3)-IIIB PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: AAC(3)-IIIB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH1; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 536056; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH1 KEYWDS ACETYLTRANSFERASE, PROMISCUITY, GNAT, ANTIBIOTIC RESISTANCE, KEYWDS 2 ANTIBIOTIC, TRANSFERASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.J.CUNEO,P.KUMAR REVDAT 3 13-MAR-24 6MB5 1 REMARK REVDAT 2 05-DEC-18 6MB5 1 JRNL REVDAT 1 07-NOV-18 6MB5 0 JRNL AUTH P.KUMAR,B.SELVARAJ,E.H.SERPERSU,M.J.CUNEO JRNL TITL ENCODING OF PROMISCUITY IN AN AMINOGLYCOSIDE JRNL TITL 2 ACETYLTRANSFERASE. JRNL REF J. MED. CHEM. V. 61 10218 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30347146 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01393 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.95 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 22640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1138 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.9613 - 4.3990 0.99 2810 164 0.1784 0.2026 REMARK 3 2 4.3990 - 3.4920 1.00 2756 152 0.2127 0.2302 REMARK 3 3 3.4920 - 3.0507 0.99 2687 159 0.2619 0.2727 REMARK 3 4 3.0507 - 2.7718 0.98 2675 131 0.2962 0.3363 REMARK 3 5 2.7718 - 2.5731 0.98 2664 129 0.3119 0.3381 REMARK 3 6 2.5731 - 2.4214 0.98 2638 136 0.3214 0.3298 REMARK 3 7 2.4214 - 2.3002 0.98 2606 154 0.3236 0.3365 REMARK 3 8 2.3002 - 2.2000 0.96 2666 113 0.3655 0.3655 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MB5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1000236471. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.6.3 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22720 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 45.951 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.53400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1-3%PEG 4000, 20-25% ISOPROPANOL,0.1M REMARK 280 HEPES, PH=7.5, PH 7.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.98000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 22.99000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 22.99000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.98000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 SER A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 PRO A 272 REMARK 465 SER A 273 REMARK 465 PRO A 274 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 67 -144.30 58.39 REMARK 500 ASP A 77 -112.81 -76.88 REMARK 500 PRO A 200 2.72 -61.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NMY A 301 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEE NCBI REFERENCE SEQUENCE: WP_088170001.1 DBREF 6MB5 A 30 274 UNP Q51405 Q51405_PSEAI 1 245 SEQADV 6MB5 MET A 1 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 THR A 2 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 SER A 3 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 4 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 THR A 5 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 6 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 SER A 7 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 PHE A 8 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 9 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 THR A 10 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ARG A 11 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 THR A 12 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 SER A 13 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 LEU A 14 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 15 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 16 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ASP A 17 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 LEU A 18 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 19 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 20 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 LEU A 21 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 GLY A 22 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 LEU A 23 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 24 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 TRP A 25 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 GLY A 26 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ASP A 27 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ALA A 28 UNP Q51405 SEE REMARK 999 SEQADV 6MB5 ILE A 29 UNP Q51405 SEE REMARK 999 SEQRES 1 A 274 MET THR SER ALA THR ALA SER PHE ALA THR ARG THR SER SEQRES 2 A 274 LEU ALA ALA ASP LEU ALA ALA LEU GLY LEU ALA TRP GLY SEQRES 3 A 274 ASP ALA ILE MET VAL HIS ALA ALA VAL SER ARG VAL GLY SEQRES 4 A 274 ARG LEU LEU ASP GLY PRO ASP THR ILE ILE ALA ALA LEU SEQRES 5 A 274 ARG ASP THR VAL GLY PRO GLY GLY THR VAL LEU ALA TYR SEQRES 6 A 274 ALA ASP TRP GLU ALA ARG TYR GLU ASP LEU VAL ASP ASP SEQRES 7 A 274 ALA GLY ARG VAL PRO PRO GLU TRP ARG GLU HIS VAL PRO SEQRES 8 A 274 PRO PHE ASP PRO GLN ARG SER ARG ALA ILE ARG ASP ASN SEQRES 9 A 274 GLY VAL LEU PRO GLU PHE LEU ARG THR THR PRO GLY THR SEQRES 10 A 274 LEU ARG SER GLY ASN PRO GLY ALA SER LEU VAL ALA LEU SEQRES 11 A 274 GLY ALA LYS ALA GLU TRP PHE THR ALA ASP HIS PRO LEU SEQRES 12 A 274 ASP TYR GLY TYR GLY GLU GLY SER PRO LEU ALA LYS LEU SEQRES 13 A 274 VAL GLU ALA GLY GLY LYS VAL LEU MET LEU GLY ALA PRO SEQRES 14 A 274 LEU ASP THR LEU THR LEU LEU HIS HIS ALA GLU HIS LEU SEQRES 15 A 274 ALA ASP ILE PRO GLY LYS ARG ILE LYS ARG ILE GLU VAL SEQRES 16 A 274 PRO PHE ALA THR PRO THR GLY THR GLN TRP ARG MET ILE SEQRES 17 A 274 GLU GLU PHE ASP THR GLY ASP PRO ILE VAL ALA GLY LEU SEQRES 18 A 274 ALA GLU ASP TYR PHE ALA GLY ILE VAL THR GLU PHE LEU SEQRES 19 A 274 ALA SER GLY GLN GLY ARG GLN GLY LEU ILE GLY ALA ALA SEQRES 20 A 274 PRO SER VAL LEU VAL ASP ALA ALA ALA ILE THR ALA PHE SEQRES 21 A 274 GLY VAL THR TRP LEU GLU LYS ARG PHE GLY THR PRO SER SEQRES 22 A 274 PRO HET NMY A 301 42 HETNAM NMY NEOMYCIN HETSYN NMY MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN FORMUL 2 NMY C23 H46 N6 O13 FORMUL 3 HOH *132(H2 O) HELIX 1 AA1 THR A 10 GLY A 22 1 13 HELIX 2 AA2 ALA A 34 GLY A 39 1 6 HELIX 3 AA3 GLY A 44 GLY A 57 1 14 HELIX 4 AA4 ALA A 70 LEU A 75 5 6 HELIX 5 AA5 TRP A 86 VAL A 90 5 5 HELIX 6 AA6 VAL A 106 THR A 113 1 8 HELIX 7 AA7 LYS A 133 ALA A 139 1 7 HELIX 8 AA8 SER A 151 ALA A 159 1 9 HELIX 9 AA9 PRO A 169 LEU A 173 5 5 HELIX 10 AB1 THR A 174 ALA A 183 1 10 HELIX 11 AB2 ASP A 224 SER A 236 1 13 HELIX 12 AB3 ALA A 254 PHE A 269 1 16 SHEET 1 AA1 7 LEU A 118 ARG A 119 0 SHEET 2 AA1 7 LEU A 127 GLY A 131 -1 O ALA A 129 N LEU A 118 SHEET 3 AA1 7 THR A 61 TYR A 65 -1 N VAL A 62 O LEU A 130 SHEET 4 AA1 7 ALA A 28 ALA A 33 1 N ILE A 29 O LEU A 63 SHEET 5 AA1 7 LYS A 162 LEU A 166 1 O LEU A 164 N MET A 30 SHEET 6 AA1 7 ALA A 247 ASP A 253 -1 O VAL A 250 N MET A 165 SHEET 7 AA1 7 ARG A 240 ILE A 244 -1 N GLY A 242 O SER A 249 SHEET 1 AA2 2 ILE A 190 THR A 199 0 SHEET 2 AA2 2 GLY A 202 PHE A 211 -1 O ILE A 208 N ILE A 193 SITE 1 AC1 17 TYR A 65 TYR A 147 ASP A 171 THR A 172 SITE 2 AC1 17 HIS A 177 THR A 213 GLY A 214 ASP A 215 SITE 3 AC1 17 GLU A 223 HOH A 401 HOH A 402 HOH A 416 SITE 4 AC1 17 HOH A 419 HOH A 439 HOH A 451 HOH A 453 SITE 5 AC1 17 HOH A 487 CRYST1 106.120 106.120 68.970 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009423 0.005441 0.000000 0.00000 SCALE2 0.000000 0.010881 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014499 0.00000